Medpace Holdings, Inc. Depreciation
Medpace Holdings, Inc. (MEDP) reported Depreciation of $6.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-23
- Medpace Holdings, Inc. depreciation for the quarter ending 2026-06-30 was $6.55M, a 3.28% decline year-over-year.
- Medpace Holdings, Inc. depreciation for the quarter ending 2026-03-31 was $6.75M, a 0.85% increase year-over-year.
- Medpace Holdings, Inc. depreciation for the quarter ending 2025-12-31 was $6.89M, a 3.51% decline year-over-year.
- Medpace Holdings, Inc. depreciation for the quarter ending 2025-09-30 was $6.81M, a 4.82% decline year-over-year.
- Medpace Holdings, Inc. depreciation for fiscal 2025 was $27.18M, a 2.27% decline from fiscal 2024.
- Medpace Holdings, Inc. depreciation for fiscal 2024 was $27.81M, a 15.25% increase from fiscal 2023.
- Medpace Holdings, Inc. depreciation for fiscal 2023 was $24.13M, a 27.07% increase from fiscal 2022.
- Medpace Holdings, Inc. depreciation for fiscal 2022 was $18.99M, a 18.64% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.55M 10-Q · filed 2026-07-23 | $13.31M 10-Q · filed 2026-07-23 | $20.20M derived: sum of 3 quarters · filed 2026-07-23 | $27.01M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $6.75M 10-Q · filed 2026-04-23 | $13.64M derived: sum of 2 quarters · filed 2026-04-23 | $20.46M derived: sum of 3 quarters · filed 2026-04-23 | $27.23M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $6.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $13.71M derived: sum of 2 quarters · filed 2026-02-10 | $20.48M derived: sum of 3 quarters · filed 2026-07-23 | $27.18M 10-K · filed 2026-02-10 |
| 2025-09-30 | $6.81M 10-Q · filed 2025-10-23 | $13.59M derived: sum of 2 quarters · filed 2026-07-23 | $20.28M 10-Q · filed 2025-10-23 | $27.43M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $6.78M 10-Q · filed 2026-07-23 | $13.47M 10-Q · filed 2026-07-23 | $20.62M derived: sum of 3 quarters · filed 2026-07-23 | $27.77M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $6.69M 10-Q · filed 2026-04-23 | $13.84M derived: sum of 2 quarters · filed 2026-04-23 | $21.00M derived: sum of 3 quarters · filed 2026-04-23 | $27.87M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $14.30M derived: sum of 2 quarters · filed 2026-02-10 | $21.18M derived: sum of 3 quarters · filed 2026-02-10 | $27.81M 10-K · filed 2026-02-10 |
| 2024-09-30 | $7.16M 10-Q · filed 2025-10-23 | $14.03M derived: sum of 2 quarters · filed 2025-10-23 | $20.66M 10-Q · filed 2025-10-23 | $27.09M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $6.87M 10-Q · filed 2025-07-22 | $13.51M 10-Q · filed 2025-07-22 | $19.93M derived: sum of 3 quarters · filed 2026-02-10 | $26.26M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $6.63M 10-Q · filed 2025-04-22 | $13.05M derived: sum of 2 quarters · filed 2026-02-10 | $19.38M derived: sum of 3 quarters · filed 2026-02-10 | $25.35M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $12.75M derived: sum of 2 quarters · filed 2026-02-10 | $18.72M derived: sum of 3 quarters · filed 2026-02-10 | $24.13M 10-K · filed 2026-02-10 |
| 2023-09-30 | $6.33M 10-Q · filed 2024-10-22 | $12.30M derived: sum of 2 quarters · filed 2024-10-22 | $17.71M 10-Q · filed 2024-10-22 | $22.77M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $5.97M 10-Q · filed 2024-07-23 | $11.38M 10-Q · filed 2024-07-23 | $16.44M derived: sum of 3 quarters · filed 2025-02-11 | $21.39M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $5.41M 10-Q · filed 2024-04-23 | $10.47M derived: sum of 2 quarters · filed 2025-02-11 | $15.42M derived: sum of 3 quarters · filed 2025-02-11 | $20.13M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $10.01M derived: sum of 2 quarters · filed 2025-02-11 | $14.72M derived: sum of 3 quarters · filed 2025-02-11 | $18.99M 10-K · filed 2025-02-11 |
| 2022-09-30 | $4.95M 10-Q · filed 2023-10-24 | $9.66M derived: sum of 2 quarters · filed 2023-10-24 | $13.93M 10-Q · filed 2023-10-24 | $18.11M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $4.71M 10-Q · filed 2023-07-25 | $8.98M 10-Q · filed 2023-07-25 | $13.16M derived: sum of 3 quarters · filed 2024-02-13 | $17.22M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $4.27M 10-Q · filed 2023-04-25 | $8.46M derived: sum of 2 quarters · filed 2024-02-13 | $12.51M derived: sum of 3 quarters · filed 2024-02-13 | $16.46M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $8.24M derived: sum of 2 quarters · filed 2024-02-13 | $12.19M derived: sum of 3 quarters · filed 2024-02-13 | $16.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $4.06M 10-Q · filed 2022-10-25 | $8.01M derived: sum of 2 quarters · filed 2022-10-25 | $11.82M 10-Q · filed 2022-10-25 | $15.35M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $3.95M 10-Q · filed 2022-07-26 | $7.76M 10-Q · filed 2022-07-26 | $11.30M derived: sum of 3 quarters · filed 2023-02-14 | $14.29M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $3.81M 10-Q · filed 2022-04-26 | $7.35M derived: sum of 2 quarters · filed 2023-02-14 | $10.34M derived: sum of 3 quarters · filed 2023-02-14 | $13.01M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $6.53M derived: sum of 2 quarters · filed 2023-02-14 | $9.20M derived: sum of 3 quarters · filed 2023-02-14 | $11.65M 10-K · filed 2023-02-14 |
| 2020-09-30 | $2.99M 10-Q · filed 2021-10-26 | $5.67M derived: sum of 2 quarters · filed 2021-10-26 | $8.12M 10-Q · filed 2021-10-26 | $10.44M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $2.67M 10-Q · filed 2021-07-27 | $5.13M 10-Q · filed 2021-07-27 | $7.45M derived: sum of 3 quarters · filed 2022-02-15 | $9.51M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.45M 10-Q · filed 2021-04-27 | $4.78M derived: sum of 2 quarters · filed 2022-02-15 | $6.84M derived: sum of 3 quarters · filed 2022-02-15 | $8.82M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $4.39M derived: sum of 2 quarters · filed 2022-02-15 | $6.37M derived: sum of 3 quarters · filed 2022-02-15 | $8.36M 10-K · filed 2022-02-15 |
| 2019-09-30 | $2.06M 10-Q · filed 2020-10-27 | $4.04M derived: sum of 2 quarters · filed 2020-10-27 | $6.04M 10-Q · filed 2020-10-27 | $8.39M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $1.98M 10-Q · filed 2020-07-28 | $3.97M 10-Q · filed 2020-07-28 | $6.33M derived: sum of 3 quarters · filed 2021-02-16 | $8.67M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $1.99M 10-Q · filed 2020-04-29 | $4.35M derived: sum of 2 quarters · filed 2021-02-16 | $6.69M derived: sum of 3 quarters · filed 2021-02-16 | $8.92M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $4.70M derived: sum of 2 quarters · filed 2021-02-16 | $6.93M derived: sum of 3 quarters · filed 2021-02-16 | $9.24M 10-K · filed 2021-02-16 |
| 2018-09-30 | $2.34M 10-Q · filed 2019-10-29 | $4.57M derived: sum of 2 quarters · filed 2019-10-29 | $6.88M 10-Q · filed 2019-10-29 | $8.99M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $2.23M 10-Q · filed 2019-07-30 | $4.54M 10-Q · filed 2019-07-30 | $6.65M derived: sum of 3 quarters · filed 2020-02-25 | $8.88M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $2.31M 10-Q · filed 2019-04-30 | $4.42M derived: sum of 2 quarters · filed 2020-02-25 | $6.66M derived: sum of 3 quarters · filed 2020-02-25 | $8.76M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $4.34M derived: sum of 2 quarters · filed 2020-02-25 | $6.44M derived: sum of 3 quarters · filed 2020-02-25 | $8.57M 10-K · filed 2020-02-25 |
| 2017-09-30 | $2.24M 10-Q · filed 2018-10-30 | $4.34M derived: sum of 2 quarters · filed 2018-10-30 | $6.47M 10-Q · filed 2018-10-30 | $8.43M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $2.10M 10-Q · filed 2018-07-31 | $4.23M 10-Q · filed 2018-07-31 | $6.19M derived: sum of 3 quarters · filed 2019-02-26 | $8.11M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $2.13M 10-Q · filed 2018-05-01 | $4.09M derived: sum of 2 quarters · filed 2019-02-26 | $6.01M derived: sum of 3 quarters · filed 2019-02-26 | $7.80M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.88M derived: sum of 2 quarters · filed 2019-02-26 | $5.67M derived: sum of 3 quarters · filed 2019-02-26 | $7.44M 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.92M 10-Q · filed 2017-10-31 | $3.71M derived: sum of 2 quarters · filed 2017-10-31 | $5.48M 10-Q · filed 2017-10-31 | $7.14M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $1.79M 10-Q · filed 2017-08-01 | $3.57M 10-Q · filed 2017-08-01 | $5.22M derived: sum of 3 quarters · filed 2018-02-27 | $6.83M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.77M 10-Q · filed 2017-05-02 | $3.43M derived: sum of 2 quarters · filed 2018-02-27 | $5.04M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.27M derived: sum of 2 quarters · filed 2018-02-27 | $6.38M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $1.61M 10-Q · filed 2016-11-03 | $4.72M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | $4.61M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |